The study also demonstrated that KMO knockdown in HCC cell lines by small interfering RNA (siRNA) transfection decreased cancer cell proliferation, thus suggesting that KMO could be a novel target for HCC treatment. This evidence concerns the gene KMO and hepatocellular carcinoma.